First-of-its-Kind immune cell therapy trial launches for Tough-to-Treat cancers
NCT ID NCT07255664
Summary
This is an early-stage trial testing a new, personalized immune cell therapy for people with metastatic colorectal or prostate cancer. Doctors take a patient's own tumor-fighting immune cells, grow large numbers of them in a lab, and give them back to the patient multiple times. The main goals are to see if this repeated treatment is safe, doable, and can help control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Krankenhaus Nordwest
RECRUITINGFrankfurt, 60488, Germany
Contact
Conditions
Explore the condition pages connected to this study.